← Leaderboards
Thomas F Gamage
Research Triangle Institute
$2,165,705
Attributed
$2,165,705
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $641.4K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,165,705 · 2
By mechanism
R01$1,358,211 · 1
K01$807,494 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Triangle Institute
Same institution · by research overlap
- Yanan Zhang$8,086,410
- Rangan Maitra$14,311,381
- Brian F Thomas$3,550,619
- William A Zule$11,167,019
- Scott P Runyon$6,910,265
Others in their field
Other Emerging Leaders on “Gtp-Binding Proteins”
- Joshua Levitz · Weill Medical Coll Of Cornell Univ$7,109,913
- Lawrence C Kuo · Mebias Discovery, Inc.$4,805,544
- James E. Barrett · Mebias Discovery, Inc.$4,805,544
- John D McCorvy · Medical College Of Wisconsin$4,765,646
- Gene Wang · People Power Company$4,747,949
- Basile Robin Tarchini · Jackson Laboratory$4,093,386
Research focus
Gtp-Binding ProteinsCnr2 GenePharmaceutical PreparationsReceptorOpioidCnr1 GeneExperimental StudyPainSignal TransductionBehaviorCannabinoidsPre-ClinicalReceptor SignalingAddictionAnandamideCareer DevelopmentAnalogCannabinoid ReceptorCellsBaseAwardAgonistAttenuatedAffinity
Grant awards (10)
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$430,630
R01 · FY2024 · AT · contact PI
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$366,661
R01 · FY2023 · AT · contact PI
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$87,979
R01 · FY2023 · AT · contact PI
In vitro and in vivo characterization of CB1 allosteric modulators$159,535
K01 · FY2022 · DA · contact PI
In vitro and in vivo characterization of CB1 allosteric modulators$8,994
K01 · FY2022 · DA · contact PI
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics$472,941
R01 · FY2021 · AT · contact PI
In vitro and in vivo characterization of CB1 allosteric modulators$168,429
K01 · FY2021 · DA · contact PI
In vitro and in vivo characterization of CB1 allosteric modulators$168,429
K01 · FY2020 · DA · contact PI
In vitro and in vivo characterization of CB1 allosteric modulators$168,429
K01 · FY2019 · DA · contact PI
In vitro and in vivo characterization of CB1 allosteric modulators$133,678
K01 · FY2018 · DA · contact PI